Trinity Biotech (TRIB) Long-Term Deferred Tax (2016 - 2025)
Trinity Biotech's Long-Term Deferred Tax history spans 17 years, with the latest figure at $3.9 million for Q4 2025.
- On a quarterly basis, Long-Term Deferred Tax fell 96.2% to $3.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.9 million, a 96.2% decrease, with the full-year FY2025 number at $3.9 million, down 96.2% from a year prior.
- Long-Term Deferred Tax hit $3.9 million in Q4 2025 for Trinity Biotech, up from $3.5 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for TRIB hit a ceiling of $103.3 million in Q4 2024 and a floor of $694000.0 in Q3 2024.
- Historically, Long-Term Deferred Tax has averaged $8.8 million across 5 years, with a median of $3.8 million in 2021.
- Biggest five-year swings in Long-Term Deferred Tax: skyrocketed 5129.87% in 2024 and later plummeted 96.2% in 2025.
- Tracing TRIB's Long-Term Deferred Tax over 5 years: stood at $4.1 million in 2021, then rose by 2.85% to $4.2 million in 2022, then crashed by 53.18% to $2.0 million in 2023, then skyrocketed by 5129.87% to $103.3 million in 2024, then plummeted by 96.2% to $3.9 million in 2025.
- Business Quant data shows Long-Term Deferred Tax for TRIB at $3.9 million in Q4 2025, $3.5 million in Q2 2025, and $103.3 million in Q4 2024.